Codexis, Inc. (CDXS) Stock Forecast

NASDAQ: CDXSAnalyst ratings, price target and estimates.

CDXS analyst forecast

as of October 18, 2026
Analyst consensus
Buy
4.38 / 5 from 8 analysts
Price target
$6.14
average of analyst targets
Upside to target
+395.4%
from the latest close
Next earnings
November 5, 2026
EPS estimate $-0.09
52-week range
$0.98 – $2.85

CDXS analyst ratings

8 analysts
Strong buy
562%
Buy
112%
Hold
225%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

CDXS price target

Price $1.24Target $6.14
52-week low $0.9852-week high $2.85

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

CDXS earnings per share estimates

Codexis, Inc. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)−$0.10−$0.11−$0.08−$0.22+56.8%2
Current fiscal year (2026)−$0.42−$0.43−$0.42−$0.47+8.7%2
Next fiscal year (2027)−$0.32−$0.32−$0.32−$0.42+24.7%2

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

CDXS revenue estimates

Codexis, Inc. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$18.7M$15.4M$21.2M+117.7%8
Current fiscal year (2026)$73.9M$72.5M$75.8M+5.0%8
Next fiscal year (2027)$87.7M$80.8M$108.9M+18.7%7

CDXS EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

CDXS revenue: reported and forecast

Reported revenueEstimate (average; low–high)

CDXS EPS estimate revisions

Codexis, Inc. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)−$0.09−$0.09−$0.08−$0.08−$0.10+11.8%1 up · 0 down
Current fiscal year (2026)−$0.35−$0.35−$0.42−$0.42−$0.42+19.7%1 up · 0 down
Next fiscal year (2027)−$0.37−$0.37−$0.32−$0.32−$0.32−13.5%1 up · 0 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

CDXS earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; CDXS beat in 4 of 12.

What analysts expect from CDXS

8 analysts cover Codexis; their consensus rating is buy (4.38 on a 1–5 scale, where 5 is a strong buy). The average price target is $6.14, 395.4% above the latest close of $1.24. Analysts expect earnings of −$0.42 per share for 2026, +8.7% from a year earlier. For 2027 the average estimate is −$0.32 per share on revenue of $87.7 million. Codexis beat the EPS estimate in 4 of the last 12 quarters.

Related: CDXS income statement, CDXS key metrics, CDXS chart. See the CDXS stock overview for the latest quote and news.

CDXS forecast FAQ

What is Codexis's price target?

The average analyst price target for Codexis is $6.14, 395.4% above the latest close of $1.24.

Is Codexis a buy, hold or sell?

Of 8 analysts covering Codexis, 5 rate it a strong buy, 1 a buy, 2 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.

What is Codexis's EPS forecast?

Analysts forecast −$0.42 per share for 2026 (range −$0.43 to −$0.42); for 2027 the estimate is −$0.32.

What is Codexis's revenue forecast?

The average revenue estimate for 2026 is $73.9 million, growth of 5.0%; for 2027 it is $87.7 million.

When does Codexis report earnings?

Codexis is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 after the market closes; the EPS estimate is $-0.09.

Does Codexis usually beat earnings estimates?

Codexis reported EPS at or above the analyst estimate in 4 of the last 12 quarters.

Biotechnology: forecast